New data from the landmark POSITIVE trial is shedding light on the potential of tildrakizumab (Ilumya) for improving quality of life in patients with psoriatic disease. “POSITIVE takes a truly holistic approach to managing psoriasis by incorporating ... [3629 chars].. reed more
